SPOTLIGHT: Novartis taps new U.S. pharma chief

The musical chairs game in Novartis' top management ranks is continuing as new pharma chief Joe Jiminez revamps the ranks. The Swiss drug maker has appointed Ludwig Hantson to top its U.S. pharmaceuticals business. Hantson takes over for Alex Gorsky, whose departure was announced in February; previously, Hantson ran Novartis' European pharma business. Report

Suggested Articles

Janssen’s BCMA-targeting CAR-T therapy eliminated tumors in 69% of patients with advanced multiple myeloma in a small phase 1 study.

In a study, BMS' CAR-T therapy banished tumors in more than half and shrank tumors in nearly three-quarters of relapsed blood cancer patients.

Novartis unveiled more data showing how its asthma combo QMF149 fared against the standard of care: a combination of the same types of drugs.